About: SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $4.84 (-3.78%)
SCYX NASDAQ Scynexis Inc
Scynexis Inc share price
SCYX price activity
Último preço
$ 4,840
Variação (24h)
-0,19 USD (-3,78%)
Volume
161.28K
Volume (média 4 sem.)
-
Abertura
$ 5,10
Variação do dia
$ 4,79 - $ 5,29
Fechamento anterior
$ 5,03
Último negócio
06 Oct, 8:17 pm GMT+0
Atrasado
06 Oct, 8:17 pm GMT+0
SCYX price performance
Atrasado
06 Oct, 8:17 pm GMT+0
quote.marketSignals